Disclosure 0001193125-26-398105-3

SEC FORM 4

$98,841.13

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 2,525 shares at $39.145 per share.

Reporting Person Savage Brian · Officer Title Interim Chief Legal Officer · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001193125-26-398105 · filed 2026-09-22 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)." Disclosed 2026-09-22. https://desqlong.com/cards/0001193125-26-398105-3 (retrieved 2026-09-26).